Latest / Ageless and Timeless Podcast® / The Truth About Menopause & Hormones with Dr. Betty Murray
Transcript
- 0:11Speaker 1: Good morning everyone.
- 0:12Speaker 2: This is Michelle Hughes from Ageless and Timeless. Well, you
- 0:16Speaker 2: know that we're what we stand for. It's all about
- 0:19Speaker 2: living the best version of ourselves and using the most contemporary,
- 0:25Speaker 2: cutting edge biohacks. That's kind of a slang word these days,
- 0:30Speaker 2: but anyway, but we try to find all the ways
- 0:35Speaker 2: that we can live better and longer. And so today
- 0:39Speaker 2: my guest is doctor Betty Murray, and she exemplifies exactly
- 0:44Speaker 2: what I just said. So we're going to talk a
- 0:46Speaker 2: lot today about how we maximize our opportunity to live
- 0:51Speaker 2: better and longer. So Betty, welcome to Ageless and Timeless.
- 0:54Speaker 3: Oh thank you for having me. I'm so excited to
- 0:57Speaker 3: be here.
- 0:58Speaker 2: Well, Betty's Betty Murray is from Well, you're from Dallas.
- 1:02Speaker 2: I mean, is that where you grew up?
- 1:04Speaker 1: Betty?
- 1:05Speaker 3: I've actually lived all over the country. I originally from
- 1:08Speaker 3: northern California.
- 1:09Speaker 1: But that's right, you told me that you are right.
- 1:11Speaker 1: So we were neighbors. Which town was.
- 1:13Speaker 3: It, Walnut Creek?
- 1:15Speaker 1: So I was born in.
- 1:16Speaker 2: Remember I remember you telling me. Okay, so you're a
- 1:19Speaker 2: transplant down to Texas. That's like so many Californians these days.
- 1:24Speaker 2: So Betty, why don't you start us off by telling
- 1:29Speaker 2: us your journey in as simple, you know, concise a
- 1:32Speaker 2: way as possible.
- 1:33Speaker 1: How did you go from there to here?
- 1:36Speaker 3: Yeah? I moved around a lot as a kid, but
- 1:38Speaker 3: you know, my journey into healthcare really came out of
- 1:42Speaker 3: my own illness. You know, I hate to say that.
- 1:45Speaker 3: You know, so many of us that sort of go
- 1:47Speaker 3: into the functional medicine arena, longevity, biohacking. It's because the
- 1:51Speaker 3: current conventional medicine sort of failed us. And you know,
- 1:55Speaker 3: I was actually swept into the technology boom in the
- 1:58Speaker 3: early nineties, so I would, you know, early early nineties,
- 2:01Speaker 3: and so while I was working for a company as
- 2:03Speaker 3: a first female hired by the CTO, you know, it
- 2:06Speaker 3: was one hundred hours a week, a very brutal environment,
- 2:08Speaker 3: I was diagnosed with colitis. So what was once kind
- 2:11Speaker 3: of an episodic digestive problem became much worse. And I
- 2:15Speaker 3: remember when I was sitting in the room and the doctor,
- 2:17Speaker 3: you know, I was asking the doctor if I could
- 2:19Speaker 3: change my diet because I didn't want to go on
- 2:21Speaker 3: the medications. I was like, these are really harsh, and
- 2:24Speaker 3: he barked this laugh in my face and said it
- 2:26Speaker 3: had nothing to do with what I ate, and of course,
- 2:30Speaker 3: you know, you'll get to know me. I had some
- 2:32Speaker 3: choice words. I was a little bit colorful, and you know,
- 2:35Speaker 3: I walked out of that and I you know, I
- 2:37Speaker 3: spent my time, you know, weight training, and I was
- 2:40Speaker 3: into diet nutrition. That's what I read about all the time.
- 2:43Speaker 3: And so I just started taking nutrition classes, first at
- 2:46Speaker 3: a kind of a community college. Then I've found a
- 2:48Speaker 3: university online and ended up going back and getting a
- 2:52Speaker 3: certification and a master's and human basically nutrition science. And
- 2:58Speaker 3: I opened our clinic. So I've had a clinic for
- 3:00Speaker 3: twenty one years in Texas, in North Texas, and we
- 3:04Speaker 3: really helped predominantly women, especially in the very beginning with
- 3:08Speaker 3: complex health problems. And then when I really entered into
- 3:11Speaker 3: so that was my mid thirties. I entered into my
- 3:14Speaker 3: late thirties, I started having a lot of hormonal problems
- 3:16Speaker 3: at the time. Even though I was connected in the
- 3:19Speaker 3: functional medicine community, I had access to the luminaries on
- 3:22Speaker 3: an OG in that community. You know, what it was
- 3:25Speaker 3: really going on is I was in very early perimenopause
- 3:28Speaker 3: after a two bol and some other stuff. We can
- 3:30Speaker 3: go into it, but at the time I was told
- 3:33Speaker 3: it was everything else. It's your drenals, it's your thyroid,
- 3:36Speaker 3: it's your this, it's your that. And what I really
- 3:40Speaker 3: recognized very quickly is, you know, all of the chronic
- 3:43Speaker 3: disease that really affects people early in life is very
- 3:46Speaker 3: very expensive and also very very disruptive or predominantly female. Right.
- 3:51Speaker 3: If we look at autoimmune disease, it's you know, ten
- 3:53Speaker 3: to one female to male. And if we look at
- 3:57Speaker 3: kind of chronic disease, women tend to live longer but
- 4:00Speaker 3: have poorer health span. And so in my late forties,
- 4:04Speaker 3: I decided to go back and get another master's and PhD.
- 4:07Speaker 3: Really the PhD, but you have to get the masters
- 4:09Speaker 3: just in case you don't finish the paper. So I
- 4:11Speaker 3: got another one of those, and I was really studying
- 4:13Speaker 3: hormone metabolism, so how our body processes hormones and the
- 4:17Speaker 3: impact on disease and longevity. And then I specifically looked
- 4:22Speaker 3: at the impact at IBS for women, and so everything
- 4:26Speaker 3: I do now is really to move women's health forward,
- 4:29Speaker 3: particularly for the midlife woman, because we get less than
- 4:33Speaker 3: one percent of research dollars, and so we have a
- 4:37Speaker 3: huge gap there, So that's my kind of place. And
- 4:40Speaker 3: it was because my perimenopause was so terrible despite being
- 4:44Speaker 3: highly connected. You know, I kept looking at it and saying, God,
- 4:46Speaker 3: if I feel this bad, how does everybody else feel?
- 4:50Speaker 1: Right? So, what happened with the colitis first? And then
- 4:53Speaker 1: the hormones?
- 4:54Speaker 3: Yeah, so the colitis, you know, for me, several things
- 4:57Speaker 3: were triggers for me. So I ended up later on
- 4:59Speaker 3: being di nose with celiac. So I'm a celiac and
- 5:02Speaker 3: and I have some other foods that really really trigger me.
- 5:05Speaker 3: You know, the microbiome was kind of out of wax.
- 5:07Speaker 3: So through nutrition supplementation and you know, really really being clean,
- 5:13Speaker 3: I've been able to control my colitis. I don't have
- 5:16Speaker 3: to be on medications and and I and and for
- 5:18Speaker 3: the most part, I'm in remission. And then you know,
- 5:22Speaker 3: for me, I ended up getting a tubul because I
- 5:25Speaker 3: didn't want to be on birth control, but I wanted
- 5:26Speaker 3: to control my fertility. I wanted to control that risk,
- 5:30Speaker 3: and I had to fight for it. You know, doctors
- 5:32Speaker 3: were like, you don't want to do that. I am
- 5:33Speaker 3: in Texas and so there, you know, somebody else feels
- 5:35Speaker 3: like they can tell you what your fertility journey should be.
- 5:39Speaker 3: And so when I finally had it done, you know,
- 5:41Speaker 3: they said, nothing will happen to you, like, it's just
- 5:43Speaker 3: we're just going to cauterize those Filippian tubes. Well, lo
- 5:46Speaker 3: and behold. Within about six months, my hair started falling out,
- 5:49Speaker 3: my periods started coming closer together. I gain I literally
- 5:53Speaker 3: gained like thirty thirty five pounds I used to I
- 5:56Speaker 3: used to live in the bodybuilding community, so I know
- 5:58Speaker 3: how to manipulate body calm position. And as a nutrition professional,
- 6:02Speaker 3: that was just hard swallow.
- 6:04Speaker 2: Right, oh, absolutely, and you couldn't and nothing you did
- 6:07Speaker 2: would change it, right because right right.
- 6:11Speaker 3: And so now at fifty six, I had no visible
- 6:15Speaker 3: ovaries and I've never had them removed. My body reabsorbed them.
- 6:20Speaker 3: So what women don't get told is when they go
- 6:22Speaker 3: in and whether it's a hysterectomy or and they leave
- 6:25Speaker 3: the ovaries, or they go in and cauterize, or you
- 6:28Speaker 3: have any kind of surgical intervention, a lot of times
- 6:30Speaker 3: the blood supply and the nerves to those organs will
- 6:33Speaker 3: get damaged and your body will reabsorb them. They dry
- 6:36Speaker 3: up like a walnut and get reabsorbed. So you know,
- 6:39Speaker 3: I think what happened is that pushed me into a
- 6:41Speaker 3: very early perimenopause. I looked more estrogen dominant. If you've
- 6:45Speaker 3: ever heard that sort of conversation before, I think, and
- 6:49Speaker 3: so you know, I was on this journey, and I
- 6:51Speaker 3: think a lot of it was I was being told
- 6:55Speaker 3: and managed as if I was very estrogen dominant, and
- 6:58Speaker 3: I think there was a lot of chaos. But I
- 7:00Speaker 3: think I should have started estrogen a lot earlier. But
- 7:04Speaker 3: I went into basically early menopause despite having all my parts,
- 7:08Speaker 3: you know, And so you know, and so I understand
- 7:12Speaker 3: when women are like, I don't understand what's happening to
- 7:14Speaker 3: my body.
- 7:15Speaker 2: Right, So define for the people that are watching today,
- 7:18Speaker 2: define estrogen dominance.
- 7:21Speaker 3: Yeah, so we have three major hormone groups. So we
- 7:25Speaker 3: have when we're talking about sex hormones, we have estrogens.
- 7:28Speaker 3: Of estrogen, we make three. The one that's most protective
- 7:31Speaker 3: is estradile, that's the one your ovaries makes. And then
- 7:34Speaker 3: we have a counterbalance hormone called progesterone. And progesterone's job
- 7:39Speaker 3: is to sort of fluctuate with estrogen and prepare the
- 7:41Speaker 3: uterine lining for implantation. If you happen to fertilize an egg.
- 7:46Speaker 3: But progesterone has impact on the brain and other things.
- 7:49Speaker 3: And those two hormones fluctuate throughout your cycle and throughout
- 7:52Speaker 3: your month. And then there's also testosterone. It doesn't fluctuate
- 7:56Speaker 3: as much, and it does decline, but declines more slowly
- 7:59Speaker 3: sort of time. And often when a woman gets into
- 8:03Speaker 3: her forties, when she starts in that sort of perimenopausal journey,
- 8:07Speaker 3: progesterone is the first hormone to decline. So it starts
- 8:11Speaker 3: to decline because you do not always ovulate, so the
- 8:13Speaker 3: egg doesn't always fly out, and that is required in
- 8:16Speaker 3: order to make progesterone. And so by default many women
- 8:20Speaker 3: in their midlife in the forties is they're going to
- 8:23Speaker 3: be estrogen dominant relative to their progesterone. And then as
- 8:28Speaker 3: you get into sort of late stage menopause, you start
- 8:32Speaker 3: to have wild fluctuations of estrogen. Then estrogen starts to decline.
- 8:37Speaker 3: Here's the thing, Michelle, that no one tells you is
- 8:39Speaker 3: you could still be having a cycle and still have
- 8:42Speaker 3: low estrogen.
- 8:44Speaker 1: Really, why is that explain that scientifically?
- 8:48Speaker 3: Yeah, So, essentially we have two hormones that come from
- 8:51Speaker 3: the brain one's called f SH follicular stimulating hormony, the
- 8:54Speaker 3: other ones called lutinizing hormone. And think of those as
- 8:57Speaker 3: the coaches or the instruction manuals that tell the ovaries, hey,
- 9:01Speaker 3: we're gonna, we're gonna, we're gonna shoot an egg out right.
- 9:04Speaker 3: So F s H and LH in particular causes the
- 9:07Speaker 3: ovary to swell like to create a little vehicle and
- 9:11Speaker 3: then to shoot the egg out. Well, what happens is
- 9:14Speaker 3: is we don't get appropriate signaling there, and then we
- 9:18Speaker 3: don't always have an egg come out right. That can
- 9:21Speaker 3: be because we are running out of eggs and so
- 9:23Speaker 3: we're a little bit low, or they don't fully develop right,
- 9:26Speaker 3: so we're born with our eggs, but they go through
- 9:28Speaker 3: so this this dormancy phase into a live phase each month,
- 9:32Speaker 3: and so if that happens, we don't necessarily have an
- 9:35Speaker 3: egg fly out. We don't get progesterones, so we don't
- 9:38Speaker 3: have as much rise. So in any cases, women in
- 9:42Speaker 3: their late forties are having the estrogen fluctuations that are
- 9:45Speaker 3: being driven by f SH and LH, but they're not
- 9:48Speaker 3: really ovulating, but they'll still have a cycle because their
- 9:52Speaker 3: estrogen is still fluctuating and and really I don't think
- 9:56Speaker 3: we understand that well enough. We haven't done enough research.
- 9:59Speaker 3: So a lot of women a sort of waiting until
- 10:01Speaker 3: their periods stop before they intervene. But the reality is
- 10:06Speaker 3: their overall levels of estrogen throughout the month are likely
- 10:10Speaker 3: low compared.
- 10:11Speaker 2: To them and when they the symptoms of that, if
- 10:15Speaker 2: they were just looking at symptom related to estrogen decline
- 10:19Speaker 2: would be what.
- 10:21Speaker 1: Cellular protection is a key component of longevity, and that's
- 10:25Speaker 1: where C sixty enters the conversation. Known for its powerful
- 10:30Speaker 1: antioxidant properties, C sixty is being explored for its role
- 10:34Speaker 1: in reducing oxidative stress and supporting cellular resilience. As interest
- 10:40Speaker 1: grows around mitochondrial health and aging at the cellular level,
- 10:44Speaker 1: C sixty continues to stand out as a fascinating area
- 10:48Speaker 1: of research and application. It's exactly the kind of forward
- 10:52Speaker 1: looking wellness solution we aim to spotlight on. Ageless and Timeless.
- 10:58Speaker 1: For more information on C sixty and how it's being
- 11:01Speaker 1: used in longevity focused routines, check the affiliate link in
- 11:06Speaker 1: the show notes, or use Ageless ten for ten percent
- 11:10Speaker 1: off your purchase of all their products.
- 11:14Speaker 3: So it could be you know obviously that most people
- 11:16Speaker 3: think of what we call the vasomotor things, the hot
- 11:18Speaker 3: flashes and night sweats. However, that's not the first ones
- 11:22Speaker 3: that show up. I would say the most common symptom
- 11:25Speaker 3: you'll hear is I don't feel like myself. Right, it's
- 11:27Speaker 3: this sort of gray not quite sure, but when we
- 11:31Speaker 3: look at the study, it's the most prevalent symptoms are
- 11:34Speaker 3: brain fog, anxiety, depression, sleep issues, fatigue.
- 11:40Speaker 1: And then what about weight gain too? Right?
- 11:43Speaker 3: Yeah, yeah, weight gain doesn't get its fair due. You know,
- 11:46Speaker 3: you've got a lot of the other kind of science
- 11:48Speaker 3: side that. It's like it's all about calories and calories out.
- 11:50Speaker 3: But we know that the loss of estrogen affects insulin sensitivity,
- 11:56Speaker 3: It affects your powerhouses, your mitochondria, it affects your body
- 12:00Speaker 3: ability to burn fat and sugar. I mean, so weight
- 12:02Speaker 3: gain is a big part of that too in many
- 12:04Speaker 3: many cases.
- 12:06Speaker 1: Yeah, because the.
- 12:08Speaker 2: A one C levels, the insulin levels tend to glucose
- 12:13Speaker 2: tend to increase, right because of the the estrogen is
- 12:16Speaker 2: not is not helping to keep them at a at
- 12:20Speaker 2: a normal level. So low estrogen causes more insulin sensitivity,
- 12:26Speaker 2: is what you were saying, okay, so so go on just.
- 12:31Speaker 3: Tell well, yeah, so actually it's it's you know, think
- 12:34Speaker 3: if your hormones as kind of like the Three Little bears,
- 12:37Speaker 3: we want the porridge just right, you know, so, so
- 12:40Speaker 3: too much estrogen can cause insulin resistance. Too little estrogen
- 12:43Speaker 3: can cause insulin resistance. It's about kind of that having
- 12:47Speaker 3: that right range. And so for for a lot of women,
- 12:50Speaker 3: we experience that sort of weight increase and all those
- 12:53Speaker 3: other pieces.
- 12:54Speaker 1: You know.
- 12:55Speaker 3: The other thing that I think is most insidious is
- 12:58Speaker 3: women will start to experienceerience the mood issues, so anxiety
- 13:02Speaker 3: and depression, like three out of five, you know, four
- 13:05Speaker 3: out of five will experience some period of depression and
- 13:09Speaker 3: or anxiety. And I think what we don't realize is
- 13:13Speaker 3: how much that impacts how we feel about ourselves and
- 13:16Speaker 3: then how we show up in relationships and work. You know,
- 13:20Speaker 3: we have this huge brain drain that also happens in
- 13:24Speaker 3: entrepreneurship and corporate America because women are now at their
- 13:28Speaker 3: kind of pinnacle of their success and they're starting to
- 13:31Speaker 3: have all these symptoms, and there's a significant portion of
- 13:34Speaker 3: them that will walk away from you know, advancement because
- 13:37Speaker 3: they just they're like, I'm not my brain's not working,
- 13:41Speaker 3: you know.
- 13:42Speaker 1: Right, So so what did you what did you do
- 13:46Speaker 1: about it? Then? What do you recommend others do if
- 13:49Speaker 1: they're facing that right now?
- 13:52Speaker 3: Yeah? So I think I think the thing that women
- 13:54Speaker 3: need to understand is that the average woman experience the
- 13:57Speaker 3: symptoms of menopause for eight years, and that's really happening
- 14:01Speaker 3: in perimenopause, right because menopause technically is one day. It's
- 14:05Speaker 3: one year from the last time you had your cycle.
- 14:08Speaker 3: So the average woman's going to experience that for eight years.
- 14:12Speaker 3: You know. For me, what really helped me was getting
- 14:15Speaker 3: my hormones balanced and actually putting estrogen in despite the
- 14:19Speaker 3: fact that I fit this sort of position or experience
- 14:25Speaker 3: of what everybody thought estrogen dominance would look like. So
- 14:28Speaker 3: getting estrogen onboard, dialed in, and also having less of
- 14:33Speaker 3: my own natural fluctuation when you're in that second half
- 14:36Speaker 3: of the cycle. Your ovaries, I like to call them
- 14:38Speaker 3: like a bungee cord. Today it's high, today it's low.
- 14:42Speaker 3: Today it's high it's low. So your ovarian function and
- 14:46Speaker 3: your production of estrogen is so volatile. A lot of
- 14:49Speaker 3: times you might feel good one day and not the
- 14:51Speaker 3: next when you put estrogen in and you even out
- 14:54Speaker 3: those peaks and valleys because you've got like a low
- 14:56Speaker 3: level that you're also supporting, you create less of that
- 14:59Speaker 3: and you get less chaos in that zone. We don't
- 15:01Speaker 3: have really great research. I mean, that's why we're building
- 15:04Speaker 3: Minerva is because we want to be able to get
- 15:06Speaker 3: the research to really be able to do that with precision.
- 15:11Speaker 3: You know. So hormone replacement, I think every woman, regardless
- 15:14Speaker 3: of age, should consider and be evaluated as an individual
- 15:19Speaker 3: for hormone replacement. The valut women would benefit regardless of age.
- 15:24Speaker 3: We have women that put on hormones twenty years ago
- 15:27Speaker 3: in their eighties and they're rocking and rolling.
- 15:29Speaker 2: Right, So what about Okay, So with estrogen, let's dissect
- 15:35Speaker 2: it a little bit more.
- 15:36Speaker 1: All right, you said estroneue, But go ahead and talk
- 15:38Speaker 1: about the three.
- 15:39Speaker 2: Estrogens and what they each mean and how they each
- 15:41Speaker 2: influence the overall effect of the outcome.
- 15:45Speaker 3: Sure, sure, so, So estradiole is the one that's most protective.
- 15:49Speaker 3: So that's the one that's made by your ovaries. We
- 15:52Speaker 3: also have another form of estrogen that is made by
- 15:55Speaker 3: your fat cells, predominantly called estrone and estrone in your
- 16:00Speaker 3: tissues can be converted to estradyel. So if I have
- 16:03Speaker 3: es strone in my breast tissues, my abdomen, my belly fat,
- 16:06Speaker 3: my body can convert it if necessary to estradyl.
- 16:09Speaker 1: When when would the body know to convert?
- 16:12Speaker 3: It's going to do that on its own, you know,
- 16:15Speaker 3: I would say, we don't necessarily understand exactly what triggers
- 16:19Speaker 3: that activity. You know, if we think about what estradel
- 16:23Speaker 3: really is is estradel has the primary function of metabolic function,
- 16:29Speaker 3: so like driving, mitochondrial function, driving, you know, brain cell
- 16:34Speaker 3: function and so. But the challenge is is es strone
- 16:39Speaker 3: if we're heavier, Let's say we'll make more s strone
- 16:43Speaker 3: when we go through menopause. Es Strone is the primary hormone
- 16:46Speaker 3: that we make, and it's more pro inflammatory, so it
- 16:49Speaker 3: doesn't have So think of your hormones as keys, and
- 16:52Speaker 3: every single cell has like a lock and key. Estra
- 16:55Speaker 3: dial is the perfect key and it makes everything work perfectly.
- 16:58Speaker 3: Estrone is kind of like a broken key and you
- 17:00Speaker 3: set up the chimney the lock. It can attach to receptors,
- 17:04Speaker 3: but it attaches to these to some of the receptors
- 17:06Speaker 3: that are less favorable, so you don't want a ton
- 17:09Speaker 3: of estrone. There's another one called estreol, and that one
- 17:13Speaker 3: is made through the detoxification pathways in the liver, so
- 17:17Speaker 3: it's part of your body's sort of packaging of these
- 17:20Speaker 3: hormones once your body's done with them to go into
- 17:23Speaker 3: the trash. Estriol is generally not very high unless we're pregnant,
- 17:28Speaker 3: but it preferentially attaches to a receptor called estrogen receptor B,
- 17:34Speaker 3: and that one is considered cancer protective, right, So we
- 17:38Speaker 3: want some estriol circulating. And then you've got xtra dile
- 17:41Speaker 3: that attaches to both estrogen receptor A and estrogen receptor B, right,
- 17:45Speaker 3: So it's never one or the other. So when you're
- 17:48Speaker 3: replacing hormones, we usually do an estra dil, and in
- 17:53Speaker 3: our world we also do estriol because we want some
- 17:56Speaker 3: of that estrogen receptor B attachment.
- 18:00Speaker 1: Basically, yeah, you don't want estrone. You don't want to
- 18:04Speaker 1: I mean add estron.
- 18:05Speaker 2: So I always when I was first learning, I remember
- 18:09Speaker 2: there was like a one two in three and three
- 18:12Speaker 2: I think was the estrone.
- 18:13Speaker 1: Right.
- 18:14Speaker 2: You never wanted to add the three, only the one
- 18:16Speaker 2: in the two. Yes, So in the in the formulations,
- 18:19Speaker 2: just to take it one step further in the in
- 18:22Speaker 2: the bioidentical world, the bhr G. What form of estra
- 18:28Speaker 2: dial which is the most common one, Let's just take
- 18:33Speaker 2: both of them.
- 18:33Speaker 1: Okay, one and two?
- 18:35Speaker 2: What form do you prefer for absorption and out you know,
- 18:40Speaker 2: the other outcome of effectiveness.
- 18:43Speaker 3: Yeah, we we use so we use for our company,
- 18:47Speaker 3: Minervas and my nerves, the telemedicine company in all fifty states,
- 18:50Speaker 3: we use a bioidentical hormone in oil and so we
- 18:55Speaker 3: use a combination called bi s. So bias is a
- 18:58Speaker 3: combination of estradye all and and estriol. And the good
- 19:03Speaker 3: thing is because it's compounded, we can change the composition
- 19:06Speaker 3: of the amount of both of those, so we can
- 19:09Speaker 3: both receptors. Some Now, if you look at the bioidentical
- 19:14Speaker 3: forms that are often used by other practitioners, like the patch,
- 19:17Speaker 3: it's solely an estra dile right, yeah, and so and
- 19:21Speaker 3: so at a minimum, at a minimum, you know, we
- 19:25Speaker 3: have to have estradyle because that's the one that provides
- 19:27Speaker 3: the primary function systemically. But I am I'm a strong
- 19:31Speaker 3: believer because of the biochemistry that we also need estriol.
- 19:35Speaker 1: So okay, So when you say in oil, how do
- 19:38Speaker 1: you take that? Is it? Is it something that you
- 19:40Speaker 1: put under your tongue or how is it? How is
- 19:43Speaker 1: it used?
- 19:45Speaker 3: Yeah? So it's topical. So it's a topical almost like
- 19:48Speaker 3: a cream. And it's in a Yeah, it's in an
- 19:50Speaker 3: organic jujoba oil. So it's it's this company. Yeah, it's patented.
- 19:56Speaker 3: So it's a patented all organic prescriptive hormone and Jojobe
- 20:00Speaker 3: oil are the only ingredients.
- 20:02Speaker 2: And baby, why did you choose that over let's say
- 20:05Speaker 2: sublingual trophies or injections or you know, other forms of application.
- 20:12Speaker 2: How did why did you choose the topical?
- 20:15Speaker 3: You know, we've used all of them. So, and I
- 20:18Speaker 3: will say, even myself, I'm kind of a human guinea pig.
- 20:20Speaker 3: I've used pellets. I've done it all because I'll do
- 20:23Speaker 3: it and then I'll run labs and see what happens
- 20:25Speaker 3: like And you know, here's the thing is most all
- 20:28Speaker 3: of whether it's injectable or whether it's the patch or
- 20:31Speaker 3: even compounded creams, have endocrine disrupting ingredients in it. There's
- 20:36Speaker 3: solvents to keep them in suspension. And so to me,
- 20:39Speaker 3: it was always odd and and less than favorable to go, Oh,
- 20:44Speaker 3: I'm going to I'm going to give you a bioidentical hormone,
- 20:46Speaker 3: but I'm going to give you an endocrine disruptor at
- 20:48Speaker 3: the same time, because those things disrupt your sex hormones.
- 20:51Speaker 3: And so I went on a search to find a
- 20:54Speaker 3: cleaner source, right, And so when I found this company Bright,
- 20:58Speaker 3: which is the pharmaceutical company that produced this, they literally
- 21:01Speaker 3: had just the hooba oil and the hormones. So I
- 21:05Speaker 3: was like, Okay, they're patented internationally worldwide to deliver hormones
- 21:09Speaker 3: and oil. They're the only company patented to do that.
- 21:12Speaker 3: And I was like, this is fantastic because the other
- 21:14Speaker 3: thing is a lot of your creams don't absorb very well,
- 21:17Speaker 3: depends on what the pace is. So a person like
- 21:20Speaker 3: from one company and it works great, and then not
- 21:23Speaker 3: ANOTHERBA oil is a waxy oil, so it sits on
- 21:28Speaker 3: the skin and absorbs very rapidly, and so it has
- 21:32Speaker 3: a very uniform absorption. And so we tested it for
- 21:35Speaker 3: two years in our clinic against you know, other forms,
- 21:39Speaker 3: whether it was compounded or patch or whatever, and really
- 21:42Speaker 3: found it to be very very effective and the cleanest form.
- 21:46Speaker 3: So that's our primary hormone that we use.
- 21:48Speaker 1: And there's a sas chicken derived is it from the ams?
- 21:53Speaker 1: It is?
- 21:54Speaker 3: I mean, is it is going to be? It is
- 21:55Speaker 3: a vegetarian form, so it is a vegetarian What is
- 21:58Speaker 3: traditionally used in almost to all compounding, you know, there's
- 22:02Speaker 3: from a from a chemical standpoint, everybody uses roughly the
- 22:06Speaker 3: same derivative.
- 22:07Speaker 2: Right, So okay, so how often do you use it
- 22:12Speaker 2: and how much?
- 22:14Speaker 3: Yeah, so it depends on the woman, right, you know.
- 22:16Speaker 3: So one of the things that was always frustrating to
- 22:18Speaker 3: me when I even when I started our clinic back
- 22:21Speaker 3: in two thousand and five, you know, I sat down
- 22:24Speaker 3: with the physicians because I'm a PhD. I'm the science
- 22:27Speaker 3: side of the medical side, and I was like, I
- 22:29Speaker 3: was very excited that we were going to be doing
- 22:30Speaker 3: bioidentical hormone replacement. And I sat down, I was like, Okay,
- 22:34Speaker 3: tell me how we calculate this because we're compounding it.
- 22:37Speaker 3: And I was really frustrated because it was like, well,
- 22:39Speaker 3: we started a low dose and then we check symptoms
- 22:42Speaker 3: and you know, thankfully we look at labs a lot
- 22:45Speaker 3: of clinicians do not, and then we sort of guessed
- 22:47Speaker 3: our way into the right dose. And I can tell
- 22:50Speaker 3: you this, Michelle, that hasn't changed in twenty three years.
- 22:53Speaker 3: I know it's damn way. And so here's what we
- 22:56Speaker 3: do know. So this is why we're building the technology platform.
- 22:58Speaker 3: We're going to capture this for each individual woman so
- 23:01Speaker 3: we can actually be predictive.
- 23:03Speaker 1: Right.
- 23:04Speaker 3: But so in most cases, we apply estrogen twice a day, right,
- 23:09Speaker 3: so in the morning and at night. And it's because
- 23:11Speaker 3: estrogen has a relatively short half life. It's not as
- 23:14Speaker 3: short as progesterone, which is extremely short, which we still
- 23:17Speaker 3: do porally, but it has a short half life. So
- 23:20Speaker 3: a lot of times if you take it in the morning,
- 23:22Speaker 3: it may be the dose may be worn off by
- 23:24Speaker 3: night and it might affect your sleep. And so we
- 23:26Speaker 3: dose a little bit in the morning and a little
- 23:28Speaker 3: bit at night. We do progesterone a lot of times
- 23:31Speaker 3: at night oral micronized because it helps me sleep. And
- 23:35Speaker 3: then testosterone we will usually dose in the morning because
- 23:38Speaker 3: it has a much longer life and in most cases
- 23:42Speaker 3: you're using it like on the forearm and then the
- 23:44Speaker 3: inner thigh.
- 23:46Speaker 1: So gtosterone is all still a cream.
- 23:49Speaker 3: It's a it's an oil. Yeah, So it's an oil,
- 23:51Speaker 3: same thing.
- 23:51Speaker 1: And what's the name of the compounding pharmacy that.
- 23:54Speaker 3: It's So it's a it's an exclusive pharmacy. It's called
- 23:57Speaker 3: Bright Yes.
- 23:58Speaker 2: Right, we are I g are I T E oh
- 24:04Speaker 2: t e right okay. And so there you're saying, they're
- 24:07Speaker 2: the only one that you could find that had.
- 24:09Speaker 3: The Yeah, they had the Yeah, they have an exclusive
- 24:13Speaker 3: worldwide patent on delivering hormones and oil.
- 24:16Speaker 1: On the on the with the Johoba oil.
- 24:20Speaker 2: I don't understand why how anybody could anybody can go
- 24:24Speaker 2: get Jojoba oil and put it in their formula.
- 24:27Speaker 1: So how do they start?
- 24:28Speaker 3: How does so they're in If somebody goes and does that,
- 24:31Speaker 3: they're violating their patent, which means they'll end up.
- 24:33Speaker 1: That's incredible that they would get a patent on Uh.
- 24:36Speaker 3: Yeah, yeah, they've had it for a vile Yeah they
- 24:39Speaker 3: had Yeah. I was surprised, but you know, I have
- 24:42Speaker 3: been looking for the cleanest possible, you know, delivery, and
- 24:46Speaker 3: so A the delivery is great, and B we saw
- 24:50Speaker 3: really really great results in lab work and also symptoms
- 24:55Speaker 3: better than creams because creams are kind of all over
- 24:57Speaker 3: the place. Injectables, you know, sometimes you get peaks and
- 25:01Speaker 3: valleys and you know, and pellets are very easy to
- 25:04Speaker 3: get too high and hard to control.
- 25:07Speaker 1: And so my.
- 25:10Speaker 2: Functional medicine doctor in Beverly Hills, he does not like
- 25:13Speaker 2: the patches. What what did you come up with as
- 25:17Speaker 2: far as conclusions about the patch?
- 25:20Speaker 3: I mean, the patches, like if we looked at your
- 25:22Speaker 3: menopause Society trained physicians, that's their go to. But here's
- 25:26Speaker 3: what we have found is, you know, most of these
- 25:29Speaker 3: are all generics. The generics change all the time. The
- 25:32Speaker 3: absorption is radically different between brands. Some of them are
- 25:35Speaker 3: just horrible.
- 25:36Speaker 1: Right.
- 25:37Speaker 3: You can get you know, patch adhesive interactions, so some
- 25:40Speaker 3: people get rashes and things like that. You know, I
- 25:44Speaker 3: will say, some people really like them, right, you know,
- 25:46Speaker 3: so our product may not be perfect for them. But
- 25:50Speaker 3: we have found that it really depends on the brand.
- 25:53Speaker 3: And those pharmacies are constantly changing brands because it's whoever
- 25:56Speaker 3: gave them the lowest price this month, and so we
- 25:59Speaker 3: you know, and and right now we have a pat shortage,
- 26:02Speaker 3: you know.
- 26:03Speaker 1: Because of thy chain. I mean, is that because they're
- 26:07Speaker 1: coming from China.
- 26:10Speaker 3: Well it was, it was occurring before everything that's happening
- 26:12Speaker 3: right now. But a all of so all of our
- 26:16Speaker 3: pharmaceutical drugs, almost every every form of generic drug is
- 26:21Speaker 3: actually made in India and a few that are made
- 26:23Speaker 3: in China, And so our supply chain is one hundred
- 26:27Speaker 3: percent outside of the United States in most cases, and
- 26:29Speaker 3: so we are subject to what's going on so between
- 26:32Speaker 3: tariffs and you know, the chaos of world wars and
- 26:35Speaker 3: all of that. You know, that does it. But I
- 26:38Speaker 3: think the other part is I think they failed to
- 26:40Speaker 3: pay attention to the FDA lifting the warning, And.
- 26:43Speaker 2: So how do you integrate the other hormones dht A, pregnantolone, thyroid,
- 26:51Speaker 2: you know.
- 26:51Speaker 1: How do you how do you get it all to
- 26:52Speaker 1: be in balance.
- 26:53Speaker 2: It's like it's like being the conductor of a big
- 26:56Speaker 2: orchestra and you have all these individual.
- 27:00Speaker 1: Instruments and they're all playing.
- 27:03Speaker 2: You know, they have to play together in order to
- 27:04Speaker 2: be a symphony, right, So how do you manage to
- 27:08Speaker 2: get all of that imbalance with individual customization?
- 27:13Speaker 3: Yeah? So, you know, I think this is where a
- 27:15Speaker 3: lot of people miss the boat, right. You know, when
- 27:17Speaker 3: they start looking for hormone replacement therapy, a lot of
- 27:20Speaker 3: clinicians out there just go, oh, you just need sex hormones.
- 27:22Speaker 3: As soon as your hot flashes go away, you're perfect.
- 27:24Speaker 3: And I'm like, these aren't magic, right. And here's the thing.
- 27:28Speaker 3: We have a great quiz that we're developing that helps
- 27:32Speaker 3: a woman understand because nine times out of ten, the
- 27:35Speaker 3: analogy you gave is perfect. If your sex hormones all
- 27:38Speaker 3: of a sudden showed up and the orchestra thought they
- 27:40Speaker 3: were playing a waltz and all of a sudden they're
- 27:42Speaker 3: playing jazz, all the other hormone systems start to freak
- 27:47Speaker 3: out and they're trying to balance, they're trying to bring hormony.
- 27:50Speaker 3: So most of the time there's other hormones that are
- 27:52Speaker 3: out of balance, the thyroid or the adrenals, or the
- 27:55Speaker 3: insulin hormones, or we've got an inflammatory response, and if
- 27:58Speaker 3: we ignore that, we miss it, and so we test
- 28:02Speaker 3: for all of it. We look at all of it,
- 28:04Speaker 3: and we're adjusting for all of it. So we also
- 28:06Speaker 3: are very very precise about replacing thyroid when necessary, with
- 28:11Speaker 3: the right combinations for that person to get the right levels,
- 28:15Speaker 3: and addressing the diet and lifestyle to make sure those
- 28:17Speaker 3: things are dialed in. You know, adrenal function and cortisol
- 28:21Speaker 3: is a big part of that because menopause is a
- 28:24Speaker 3: high cortisol time period, like you have no recovery hormones,
- 28:28Speaker 3: and so if you automatically already have other things contributing
- 28:31Speaker 3: to that, you're never gonna feel awesome even if you
- 28:33Speaker 3: get sex hormones on board.
- 28:36Speaker 2: And do you get a lot of resistance from people
- 28:38Speaker 2: from women to take and taking testosterone, you.
- 28:43Speaker 3: Know, I you know, I think we've done a really
- 28:45Speaker 3: good job of explaining the necessity of testosterone and just
- 28:49Speaker 3: the the myopic view of the FDA that it's not
- 28:53Speaker 3: necessary for women. Most of our women really want testosterone,
- 28:58Speaker 3: you know, because they recognize that it's a that's it's
- 29:00Speaker 3: a brain hormone first and foremost, right, right, and so
- 29:04Speaker 3: and so we don't get a lot of pushback there,
- 29:07Speaker 3: you know.
- 29:07Speaker 2: Well, and also with the g LP ones, you know,
- 29:09Speaker 2: and the scyclopaenia threat muscle loss, more and more people
- 29:15Speaker 2: are realizing more and more women are realizing they need
- 29:18Speaker 2: to get testosterone because that helps with not only with
- 29:21Speaker 2: their libido, which often has a negative impact in menopause,
- 29:26Speaker 2: but but really with the muscle building and maintenance of muscle.
- 29:31Speaker 2: The muscle loss is probably one of the biggest causes
- 29:34Speaker 2: of aging. Yeh, and GLP ones you know, have only
- 29:39Speaker 2: accelerated that the potential.
- 29:41Speaker 1: So protein protein protein, you know.
- 29:46Speaker 3: So pregnant alone, So pregnant alone. I don't think that
- 29:49Speaker 3: sits fair due, right, So pregnant alone for everybody. That
- 29:52Speaker 3: is the parent hormone or the precursor hormone for all
- 29:55Speaker 3: of our other hormones.
- 29:56Speaker 1: I know. And why is it that it gets so
- 29:58Speaker 1: little attention?
- 29:59Speaker 3: I think a lot of it's the we really haven't
- 30:00Speaker 3: done the due diligence on studying it. You know, it's
- 30:03Speaker 3: highly concentrated in the brain, it's the precursor. You know,
- 30:08Speaker 3: it really deserves a bigger do, right, because even when
- 30:12Speaker 3: you look at what's an optimal level, I don't I
- 30:15Speaker 3: wouldn't say that we have really great research to say it, right,
- 30:18Speaker 3: Like from even a functional standpoint, we always like it
- 30:20Speaker 3: on the higher end. But could we you know, could
- 30:22Speaker 3: we possibly point to and say this is why we
- 30:25Speaker 3: don't have that. But it gets it does get missed,
- 30:27Speaker 3: and you know DHA also the thing.
- 30:30Speaker 1: Is just.
- 30:32Speaker 2: Was my next point, Yeah, so go ahead on d
- 30:34Speaker 2: g A because that again it's you know, oftentimes not
- 30:38Speaker 2: even tested and then they get You know, there's always
- 30:41Speaker 2: this distinction between seven keto dh g A and regular
- 30:45Speaker 2: d A g A d Regular d A g A
- 30:47Speaker 2: is what helps with the sex hormones, but oftentimes doctors
- 30:51Speaker 2: give you the seven keto form which doesn't do anything
- 30:54Speaker 2: for that.
- 30:55Speaker 1: So I think there's so much confusion. But just talk
- 30:58Speaker 1: about th GA for a moment.
- 30:59Speaker 3: Yeah, So DHDA DGA is really a counterbalance hormone. It's
- 31:03Speaker 3: it's your primary anabolic hormone to offset cortisol. So its
- 31:08Speaker 3: job is to really support responding to stressors and getting
- 31:12Speaker 3: back to an anabolic state. And it is the precursor
- 31:15Speaker 3: for testosterone and andstine dionne seven keto. Seven keto has
- 31:20Speaker 3: been shown in early studies in the nineties to help
- 31:23Speaker 3: a little bit with lean body mass, but it is
- 31:25Speaker 3: not It is not a precursor to your other hormones. However,
- 31:29Speaker 3: what I also want to say is, as a lot
- 31:31Speaker 3: of especially telemedicine companies that haven't gone down the road
- 31:35Speaker 3: to prescribe testosterone like we do it in all fifty states,
- 31:39Speaker 3: you know, but they will lie to women and say
- 31:41Speaker 3: DHDA is equivalent and we can help you raise your androgens.
- 31:45Speaker 3: And I'm like I have yet to see that raise
- 31:48Speaker 3: testosterone enough to be any bit functional without causing hair
- 31:53Speaker 3: loss and acne and a bunch of other things. Like
- 31:55Speaker 3: they act independently and they are different. We look at it,
- 31:59Speaker 3: we look at DH sulfate, we look at the levels
- 32:02Speaker 3: we restore it, and for the most part, women don't
- 32:04Speaker 3: need really high levels. We just need consistent levels.
- 32:07Speaker 2: Yeah, so what do you consider to be a good
- 32:09Speaker 2: level of DHA depends on.
- 32:11Speaker 3: How where you're looking at it. I prefer it in urine.
- 32:14Speaker 3: I prefer looking at DH sulfate in urine. And if
- 32:17Speaker 3: we look at like the Dutch tests, you know, their
- 32:20Speaker 3: reference range goes for a midlife woman goes from like
- 32:23Speaker 3: thirty to I think seven to fifty, you know, which
- 32:26Speaker 3: is crazy. I like it in the if you look
- 32:28Speaker 3: in blood, I like it in the you know, one fifties.
- 32:30Speaker 1: And that's where that's where I am. I'm one sixty,
- 32:35Speaker 1: I think.
- 32:35Speaker 2: But what about Okay, so let's talk about the big
- 32:38Speaker 2: tee thyroid.
- 32:39Speaker 1: That's probably one of the most underdiagnosed.
- 32:41Speaker 2: Conditions in our medical world and the allopathic side, but
- 32:46Speaker 2: even the functional medicine people still miss a lot about
- 32:50Speaker 2: you know.
- 32:50Speaker 1: Oh you must you're just just aging.
- 32:53Speaker 2: But yet you know, I feel badly on my hands
- 32:56Speaker 2: and feed er cold, I'm gaining weight, I.
- 32:58Speaker 1: Have bad moods.
- 32:59Speaker 2: And and then your thywood gets tested and it's normal,
- 33:03Speaker 2: but yet it isn't really normal.
- 33:04Speaker 1: So what how do you deal with that? I'm sure
- 33:06Speaker 1: you face yeah frequently.
- 33:09Speaker 3: Yeah, And I think you know, if we look at
- 33:10Speaker 3: conventional medicine, they just look at tsh, which isn't even
- 33:13Speaker 3: a thyroid hormone, it's a PA. And then if and
- 33:17Speaker 3: then if they look further, they look at T four,
- 33:19Speaker 3: which again is not an active hormone. It must have
- 33:21Speaker 3: hyodine molecule removed. So the first thing is testing all
- 33:24Speaker 3: the way to free T three and looking for antibodies
- 33:27Speaker 3: right and reverse three to see because reverse T three
- 33:30Speaker 3: is sort of a fake version that blocks the real hormone.
- 33:34Speaker 3: So it's very important to see that and adjust accordingly
- 33:38Speaker 3: to make sure that we get that T three level
- 33:40Speaker 3: up into a therapeutic range, because a lot of people
- 33:43Speaker 3: get prescribed things like your you know, your synthroid lebothoroxin
- 33:48Speaker 3: which never raises their T three right and yeah, and
- 33:53Speaker 3: so that depends on the IDEO gene and whether you
- 33:56Speaker 3: can actually convert very well. Like I have mutations on
- 33:59Speaker 3: all of them. I don't convert T three very well.
- 34:01Speaker 3: So I act personally. I take an NP thyroid plus
- 34:05Speaker 3: CIDAML or compounded T three. I take twice a day
- 34:09Speaker 3: because T three. T three is a very fast acting
- 34:12Speaker 3: hormone and so its half life is short, so you
- 34:15Speaker 3: might need to dose it twice. So what I do.
- 34:18Speaker 1: I take the NV as well the natural.
- 34:21Speaker 2: I never take any pharmaceutical drugs if I can help it.
- 34:25Speaker 1: But I've been on two grains.
- 34:29Speaker 2: Now is that do you think that's a little too
- 34:32Speaker 2: high for I mean my five woid my T three
- 34:35Speaker 2: was like two point five.
- 34:37Speaker 1: I think on the.
- 34:37Speaker 2: Last test that's a little bit low, isn't it borderline low?
- 34:42Speaker 3: Yeah? That's low. Yeah, that's still low.
- 34:44Speaker 1: You know.
- 34:44Speaker 3: The thing is is so like if we look at
- 34:47Speaker 3: NP thyroid or armor, they're done in grain size. So
- 34:51Speaker 3: what I would say is it depends on how much
- 34:53Speaker 3: you need to get into your right amount, because you
- 34:55Speaker 3: could be on one grain, two grain three four. What
- 34:59Speaker 3: maybe more important is NP thyroid has has basically a
- 35:04Speaker 3: little bit of T four and a little bit of
- 35:05Speaker 3: T three, except you still may not convert your own
- 35:09Speaker 3: very well. Right, So if you're on that and it
- 35:11Speaker 3: doesn't seem to braize it, that's where it might make
- 35:13Speaker 3: sense to put some just separate T three in, you know,
- 35:18Speaker 3: because because that that's where the rubber hits the road.
- 35:22Speaker 3: Is truly getting that T three level into a range
- 35:24Speaker 3: that works?
- 35:26Speaker 1: And Betty, what about T two? Yeah, it talks about that.
- 35:30Speaker 3: Yeah, yeah, you know my friend doctor Amy Horneman, I
- 35:33Speaker 3: would say it's probably the you know, one of the
- 35:35Speaker 3: experts in this arena. But T two is also metabolically active,
- 35:38Speaker 3: but we don't prescribe it.
- 35:40Speaker 2: You know, she's a really good friend of mine too,
- 35:42Speaker 2: and I knew we had her in common. I remembered
- 35:45Speaker 2: that when we first talked, but she just this morning
- 35:49Speaker 2: had an email out. You probably got it about you know,
- 35:53Speaker 2: how to recognize t T two and then.
- 35:57Speaker 1: How how do it supplement for it if you need it?
- 36:00Speaker 2: But how do you know if you need it if
- 36:02Speaker 2: it doesn't get tested.
- 36:03Speaker 1: On blood work? Now, so how do you know if
- 36:05Speaker 1: you need to add T two to your You.
- 36:08Speaker 3: Know, what I think about is if we're doing like
- 36:10Speaker 3: if we've done Armor or Nature Thrower or NP thyroid
- 36:14Speaker 3: and we're not getting better, then we look at T
- 36:15Speaker 3: three right and we're not getting better, then then a
- 36:19Speaker 3: lot of times at that point it might be worthwhile
- 36:22Speaker 3: to try a T two, you know. And you know,
- 36:25Speaker 3: I think the hardest thing is whether the FDA is
- 36:27Speaker 3: going to come down on that being over the counter.
- 36:30Speaker 1: You know.
- 36:30Speaker 2: But she has a supplement in her Fixer formula, right,
- 36:33Speaker 2: fix T two, and she she actually touts it for
- 36:36Speaker 2: weight management quite a bit, which you know, I think
- 36:40Speaker 2: gets a lot of attention from a lot of people,
- 36:43Speaker 2: but may not be the only reason you would ever
- 36:46Speaker 2: want to take T two. But I think the most
- 36:49Speaker 2: important thing that we have to let people understand is
- 36:52Speaker 2: it T four, which is normally what these drugs are
- 36:58Speaker 2: are ingredients. T four is a it's a passive hormone.
- 37:04Speaker 2: I mean it's it's doesn't do anything. It's just a reserve.
- 37:09Speaker 2: And if you don't convert T four to T three,
- 37:12Speaker 2: which is the active form, then you're not going to
- 37:16Speaker 2: have you know, the results with your symptoms being reduced.
- 37:20Speaker 2: And then you've got the TSH which, like you said,
- 37:22Speaker 2: it's a pituitary it's not even it's not even a
- 37:26Speaker 2: thyroid home So why why and how have they come
- 37:29Speaker 2: to measure only that to look at your thyroid and
- 37:33Speaker 2: not the rest of the picture.
- 37:34Speaker 1: Why do you think that happened?
- 37:37Speaker 3: You know, I think you know, if we look at
- 37:40Speaker 3: how medicine sort of evolved, you know, most of are
- 37:44Speaker 3: what we would consider western medicine or conventional medicine came
- 37:48Speaker 3: out of warfare and infection, and then it came out
- 37:51Speaker 3: of drug development. You know, it was really Kellogg that
- 37:54Speaker 3: did that. You know, they did the Flexner Report and
- 37:56Speaker 3: sort of you know, ended a homeopathic and chiro practic
- 38:00Speaker 3: and other schools that rivaled the amount of medical schools
- 38:04Speaker 3: we had back in the early nineteen hundreds. But essentially
- 38:07Speaker 3: what happened is drug discovery and pharmaceutical companies really took
- 38:13Speaker 3: hold of the medical community at that point.
- 38:15Speaker 1: And so.
- 38:17Speaker 3: You know, for instance, armor thyroid was grandfathered by the
- 38:20Speaker 3: FDA because it existed before the FDA. Well long come synthroid, right,
- 38:26Speaker 3: synthetic patented now it's generic. But so there's always been
- 38:31Speaker 3: this pushback because the pharmaceutical companies want control, and because
- 38:35Speaker 3: of that, they control the education, they control the testing paradigm.
- 38:40Speaker 3: So you know, what gets told the doctors that is
- 38:42Speaker 3: considered standard of care and so it really leaves the
- 38:46Speaker 3: personalization out, which is inappropriate to this point. We have
- 38:50Speaker 3: the capacity to personalized medicine to the biochemistry of the
- 38:53Speaker 3: individual in front of us.
- 38:56Speaker 2: So when you put the hormones into the big picture
- 38:59Speaker 2: of your overall health and wellness well being, how do
- 39:03Speaker 2: you how do you integrate that?
- 39:05Speaker 1: How do you describe to.
- 39:06Speaker 2: Your patients where the hormones fit in all of this,
- 39:11Speaker 2: because there's so many other aspects of good health. But
- 39:14Speaker 2: so tell us how you describe and help your patients
- 39:17Speaker 2: to understand the importance of hormones.
- 39:20Speaker 3: Yeah, so we have to remember that our entire body
- 39:23Speaker 3: runs on hormones. So I like to think of it
- 39:25Speaker 3: this way. So if we all remember Katrina, right, So
- 39:28Speaker 3: Katrina was catastrophic, massive destruction. What's the first thing that
- 39:33Speaker 3: they put in when they started to like recover Katrina.
- 39:36Speaker 3: It was communications, right, They restored line communications, cellular communications,
- 39:43Speaker 3: waki taki, all that stuff. Your hormones are the communicators
- 39:47Speaker 3: in your body. So they communicate between cells, they communicate
- 39:50Speaker 3: between organs, and they're the ones that tell things to
- 39:53Speaker 3: do things. And so when we lose those primary sex
- 39:57Speaker 3: hormones that are because of a right we weren't designed
- 40:01Speaker 3: to live thirty five years postmenopausally, we just weren't right
- 40:04Speaker 3: were Our life expectancy has far exceeded our ovarian age.
- 40:09Speaker 3: And when we lose those, what happens is all of
- 40:12Speaker 3: the messengers that say, hey, stay vital, keep the mitochondria cooking,
- 40:17Speaker 3: you know, keep everything moving at high speed, and keep
- 40:20Speaker 3: me young and fertile goes to sleep. And then all
- 40:26Speaker 3: the other messenger systems, like insulin as a messenger and
- 40:29Speaker 3: as a communicator, all of them start to go sideways.
- 40:33Speaker 3: So when you restore hormone function, not back to a
- 40:36Speaker 3: twenty year old but physiological, right, you get enough in
- 40:40Speaker 3: there so the body can do what it needs to
- 40:41Speaker 3: do and gets the right messages that then allows for
- 40:44Speaker 3: all the other stuff. Right. I also hear practitioners all
- 40:48Speaker 3: the time. We'll say, well, they have to earn their hormones,
- 40:52Speaker 3: Like I won't put you on hormones until you do
- 40:54Speaker 3: X y Z. I'm like, put them on hormones so
- 40:56Speaker 3: they can go to sleep, get to the gym, not
- 40:59Speaker 3: want a screen with your children, you know, like, like
- 41:02Speaker 3: the hormones are so important. Every single cell but two
- 41:05Speaker 3: has an estrogen receptor, right.
- 41:08Speaker 1: And what are the two that don't.
- 41:09Speaker 3: There's a single cell in the brain, like one of
- 41:12Speaker 3: the I can't remember. It's not the glial cell. But
- 41:14Speaker 3: there's a single brain cell that doesn't have a receptor
- 41:17Speaker 3: and red blood cells everything else does.
- 41:19Speaker 1: Oh really, I didn't know about the red blood cells.
- 41:21Speaker 2: So how do you? I always say the hormones are
- 41:25Speaker 2: the super highway of your body. So you you know,
- 41:29Speaker 2: you just cannot function if your hormones are out of balance.
- 41:33Speaker 1: So to me, it's like the foundational step yep to good.
- 41:37Speaker 2: Well, first getting your genetics tested so you know if,
- 41:41Speaker 2: like you said, you're a slow converter, and so you know,
- 41:45Speaker 2: that helps you to know how to then dose for
- 41:49Speaker 2: that deficiency. So I always, you know, say that your
- 41:53Speaker 2: genetics tests are like it's like building a house. I
- 41:56Speaker 2: was telling my girlfriend that I was referring to you yesterday.
- 42:00Speaker 2: I was telling her, you know, you wouldn't build a
- 42:02Speaker 2: house without a foundation. Well, okay, so know your genetics
- 42:06Speaker 2: because they don't change right now. Epigenetics means that you can,
- 42:10Speaker 2: you know, live, you can like like I have the
- 42:13Speaker 2: obesity gene and I'm like a size six way one
- 42:16Speaker 2: hundred and.
- 42:17Speaker 1: Fifteen and it's five 't six. Yeah, it might have
- 42:21Speaker 1: been in my family, but I've been disciplined enough.
- 42:24Speaker 2: So epigenetics is you're how you make your choices for
- 42:28Speaker 2: your lifestyle. So but anyway, the point I was making
- 42:32Speaker 2: is so many doctors, allopath do not even ask you
- 42:35Speaker 2: to test for your hormones. That's it's just like it's
- 42:38Speaker 2: to me, that's such a crime against humanity. So well,
- 42:43Speaker 2: then talk a little bit about stress, because today's world
- 42:47Speaker 2: is so stressful, and everybody is talking about the gut
- 42:51Speaker 2: brain access and how peptides are changing, the you know,
- 42:57Speaker 2: the mitochondria and the metabolic drain. But yet still people,
- 43:03Speaker 2: stress is still the killer. So I know you deal
- 43:07Speaker 2: a lot with it because and you're dealing with women
- 43:09Speaker 2: who are you know, hormone deficient. So stress is going
- 43:11Speaker 2: to be one of the big complaints. So what are
- 43:14Speaker 2: some of the conclusions that some of the protocols that
- 43:18Speaker 2: Union used for stress management.
- 43:21Speaker 3: Yeah, you know, if we look at because we do
- 43:23Speaker 3: genetics and then we look at your epigenetics, so your
- 43:25Speaker 3: phenotype the combination of those two things, and we would
- 43:28Speaker 3: look at it from a hormonal sort of phenotype. You know,
- 43:32Speaker 3: I would say sixty percent of the time, there's a
- 43:34Speaker 3: cortisol issue. Right, it's just you know, because none of
- 43:37Speaker 3: us had the last three or four decades that weren't stressful.
- 43:41Speaker 3: And so, but the challenge is, and I'll tell you
- 43:43Speaker 3: from my own experience, I'm I'm a type A, hard driving.
- 43:47Speaker 3: I'm not Type A necessarily with my family, but I
- 43:49Speaker 3: am frighteningly driven. And so I was very much one
- 43:52Speaker 3: of those people when I was younger that I'll sleep
- 43:54Speaker 3: when I'm dead, Right, I was like, well, anyway, who cares,
- 43:56Speaker 3: I'm just gonna keep going. But here's the thing, there's
- 43:59Speaker 3: not a supplement. I don't care, I don't care what
- 44:01Speaker 3: somebody sells you. There is not a supplement on the planet.
- 44:03Speaker 3: There is not a drug on the planet that can
- 44:05Speaker 3: override your bodi's need for rest and restoration, right, And
- 44:10Speaker 3: so you know, we have to look at it. So
- 44:12Speaker 3: we have to identify what's going on your metabolized cortisol,
- 44:15Speaker 3: the free cortisol, But we have to ingrain the lifestyle
- 44:20Speaker 3: on top of it to help, right, So we have to,
- 44:23Speaker 3: Like one of the things that I see Michelle all
- 44:24Speaker 3: the time is like boundaries, Right, that's like one of
- 44:28Speaker 3: the most powerful thing for a woman to do is
- 44:30Speaker 3: to finally say no.
- 44:33Speaker 2: There's set boundaries, right, yes, and the willingness to say no,
- 44:38Speaker 2: like you're so right, you're so right.
- 44:40Speaker 3: Yeah, and so we look at all of that. So
- 44:42Speaker 3: we have you know, the women that work with our
- 44:44Speaker 3: telemedicine company. We do the hormones, we do the thyroid,
- 44:47Speaker 3: we look at the adrenals, we look at the gut,
- 44:48Speaker 3: we look at the genetics, we look at all of that.
- 44:51Speaker 3: And then we also have we have community. We have
- 44:53Speaker 3: health coaches and part of the health coach's job is
- 44:56Speaker 3: to help you get through enabling yourself to get better, right,
- 45:00Speaker 3: because we have to often get better in an environment
- 45:02Speaker 3: that makes us sick, right, and so and so I
- 45:06Speaker 3: think that's so important is that we have to understand
- 45:09Speaker 3: and and I think some of the beauty of midlife is,
- 45:12Speaker 3: you know, we are less accommodating of other people's bs anymore,
- 45:17Speaker 3: which is beautiful. I'm like, I was like, pull on
- 45:20Speaker 3: that cord, right, don't and put yourself first a couple
- 45:24Speaker 3: of times, right, so we can start feeling better because
- 45:26Speaker 3: this is this is really the time period of life
- 45:29Speaker 3: where we have agency. We have more agency than we
- 45:32Speaker 3: ever had. Our ability to make decisions about our own life.
- 45:35Speaker 3: We have access in many cases where we didn't have
- 45:37Speaker 3: it before to things, and we have assets, and this
- 45:41Speaker 3: is the time in which to use the assets to
- 45:43Speaker 3: do the things that we want to do.
- 45:45Speaker 2: And so we It's like, if you need an answer
- 45:47Speaker 2: to a question, just go on chat GBT. You're going
- 45:50Speaker 2: to get at least one version of after they you know,
- 45:53Speaker 2: source the whole internet, but it comes in a nanosecond,
- 45:57Speaker 2: so you know, you're impatience to get answers is completely
- 46:02Speaker 2: quelled because you no sooner have the question.
- 46:06Speaker 1: On the page than you're having the answer.
- 46:08Speaker 2: It's it's just kind of an amazing Well does Minerva
- 46:11Speaker 2: use all of this AI and how does that all work?
- 46:15Speaker 3: Yeah? So right NOWVA Minerva is really two sides. So
- 46:18Speaker 3: Minerva on one side is the telemedicine. So we have
- 46:21Speaker 3: menopause method trained physicians and clinicians in all fifty states
- 46:26Speaker 3: that provide bioidentical hormone replacement and they work together with
- 46:31Speaker 3: our nutritionness and health coaches and we help somebody get
- 46:34Speaker 3: and stay well looking at genetics and hormone testing and
- 46:38Speaker 3: all of that. So we get that dialed in and
- 46:40Speaker 3: on the other side, this is the technology we're building.
- 46:42Speaker 3: So we raised capital and we're still raising capital. We
- 46:46Speaker 3: raise capital and so this we were hoping to be
- 46:48Speaker 3: out by September. The first stage of it will be
- 46:51Speaker 3: an app. So imagine you download an app and you're
- 46:54Speaker 3: going to capture some information about your own symptoms. If
- 46:57Speaker 3: you're wearing wearables, right, you can capture all that information.
- 47:00Speaker 3: You can connect all of them. If you're like me,
- 47:02Speaker 3: I have multiples, so I have bunches of those doing that.
- 47:05Speaker 3: And what it starts to do is it's using AI
- 47:07Speaker 3: and it's constantly reading what you experiences, what responses you have,
- 47:12Speaker 3: What do your wearables say, If you took a picture
- 47:15Speaker 3: of your food, what's your macros that you're eating, And
- 47:17Speaker 3: it's giving feedback, So it's giving feedback to you and
- 47:20Speaker 3: also giving feedback if you're working with one of our clinicians,
- 47:23Speaker 3: so your provider knows exactly what's going on. But ultimately,
- 47:27Speaker 3: what it allows a woman to do is order her
- 47:29Speaker 3: own labs, look at her own wearable data and CGM
- 47:32Speaker 3: and all that stuff, and understand her own body as
- 47:34Speaker 3: an end of one right, and we can get predictive, proactive,
- 47:38Speaker 3: and preventative right, we can start telling you. We can
- 47:40Speaker 3: get in front of it, and we can say, hey, Michelle,
- 47:42Speaker 3: we've seen this trend happen and these three things are
- 47:45Speaker 3: going on, so here's what you should do next. Right,
- 47:48Speaker 3: we can get to you before it becomes a problem.
- 47:51Speaker 3: And then ultimately, if somebody is working with our telemedicine team,
- 47:54Speaker 3: as we build this technology, we're also going to capture
- 47:57Speaker 3: what are you taking medically and supplementally, how do you
- 48:00Speaker 3: metabolize those hormones, because that's where my PhD research resided,
- 48:05Speaker 3: And then how are you taking your hormones? So what
- 48:07Speaker 3: dose did you start at? What dose did you end
- 48:09Speaker 3: up at? So we can actually collapse that gap and
- 48:12Speaker 3: be able to say, based on all this data, we
- 48:15Speaker 3: know the dose that you should be on, right, and
- 48:17Speaker 3: we can get clos through instead of guessing. And so
- 48:20Speaker 3: we're building that technology right now, so we'll essentially be
- 48:23Speaker 3: able to, you know, privatize health to women from the
- 48:27Speaker 3: comfort of their own hand, right in their own.
- 48:30Speaker 1: And you know, you say fifty states, but that's not
- 48:33Speaker 1: a small task. How did you ever get certified?
- 48:37Speaker 4: Yeah?
- 48:41Speaker 1: So how did you do that?
- 48:43Speaker 3: Yeah? So I so personally, I'm a PhD. So I'm
- 48:45Speaker 3: the science behind the entire thing. So obviously I have
- 48:48Speaker 3: clinicians that work for me in my clinic in Dallas.
- 48:50Speaker 3: So we have a clinician team. So we have a
- 48:52Speaker 3: team of providers that are licensed because each state has
- 48:55Speaker 3: different separate licensing, so they're licensed in all fifty states.
- 48:58Speaker 3: So we have a team of medical providers. I don't
- 49:00Speaker 3: actually see patients anymore, but we have a team that
- 49:03Speaker 3: are all trained, certified. They know exactly how our method
- 49:07Speaker 3: works and so and so that allows us to then deliver.
- 49:11Speaker 3: But then when we have the technology, we can hyper
- 49:13Speaker 3: personalize for every for every woman.
- 49:18Speaker 2: So how many patients do you have throughout the fifty shades?
- 49:22Speaker 3: Yeah, so we so this last year, so we built
- 49:25Speaker 3: the telemedicine side first, so we brought on one hundred
- 49:28Speaker 3: one hundred patients as sort of our first cohort. And
- 49:33Speaker 3: then we are launching kind of the newest version of
- 49:37Speaker 3: our our our systems and products and the new pharmaceutical.
- 49:41Speaker 3: We're launching that in the next month and so that
- 49:44Speaker 3: will be the new one and we're going to start
- 49:46Speaker 3: bringing on a lot more patients.
- 49:48Speaker 2: So so so let me be sure I understand this
- 49:50Speaker 2: Benish for everybody else too. You know, maybe it sounds redundant,
- 49:55Speaker 2: but you're saying that you when you had the vision
- 49:58Speaker 2: to build MINU, you saw that fifty states was your universe.
- 50:04Speaker 1: That's where you're starting. It's not international, it's fifty states.
- 50:07Speaker 2: But you then went and hired clinicians in each state
- 50:11Speaker 2: that were certified or thought licensed in those states. So
- 50:17Speaker 2: you had to look at fifty different states and find
- 50:20Speaker 2: the right person to come in to be part of
- 50:22Speaker 2: this team, right am I right on.
- 50:24Speaker 3: That, Yeah, And we had to make sure they were
- 50:26Speaker 3: trained in the methods and the ways that we have
- 50:30Speaker 3: identified to treat It took two and a half years.
- 50:33Speaker 3: It took two and a half years to.
- 50:34Speaker 2: Build our initial peace couldn't have been a one month effort.
- 50:38Speaker 3: No, this is this is a long haul R and so.
- 50:42Speaker 1: Now and the vision is now to.
- 50:46Speaker 2: Get more patients, is not to add more places locations
- 50:50Speaker 2: in right.
- 50:51Speaker 3: Yeah, right now? So yeah, right now we will be
- 50:53Speaker 3: bringing on new patients. Right so, we were bringing on
- 50:55Speaker 3: new patients. We have clinicians that are getting trained, so
- 50:58Speaker 3: we can definitely flex and grow, and we're building the
- 51:01Speaker 3: technology and so we're staying in the United States right now.
- 51:04Speaker 3: Now personally, I would love to take this international, but
- 51:07Speaker 3: each country has even like Canada, Canada is not all
- 51:11Speaker 3: the same. Quebec is different than the rest of it,
- 51:13Speaker 3: so they all have different licensures. We would love to
- 51:16Speaker 3: be international at some point, at least our technology at
- 51:19Speaker 3: a minimum, right, you know, if we could get our
- 51:20Speaker 3: technology and our training out there, that would be awesome.
- 51:24Speaker 3: But really starting in all fifty states was kind of
- 51:27Speaker 3: our first major hurdle.
- 51:30Speaker 1: So then how does Minerva fit with Living Well, the
- 51:34Speaker 1: clinic that you started in Dallas?
- 51:36Speaker 3: Yeah, yeah, you integrate. Yeah, so the clinics. So the
- 51:39Speaker 3: clinic we actually do a lot more than what we
- 51:41Speaker 3: can do in telemedicine. Right, So I have a DEXA device,
- 51:44Speaker 3: I have a functional qEEG. We have psychiatry. So we
- 51:48Speaker 3: are a multi specialty clinic. And so Living Well Dallas
- 51:52Speaker 3: is a separate entity, but it has been the think
- 51:54Speaker 3: tank and sort of the center of excellence where we've
- 51:58Speaker 3: developed our methods and and really did the work right.
- 52:02Speaker 3: And so the twenty one years and the tens of
- 52:04Speaker 3: thousands of patients that we've helped over the years helped
- 52:07Speaker 3: create basically the framework in which to bring Minerva to
- 52:11Speaker 3: the to the masses.
- 52:13Speaker 2: Yea, So living well Dallas means you have to come
- 52:16Speaker 2: and be physically present to be a patient there.
- 52:20Speaker 3: Yeah, we do get people that fly in. So we
- 52:23Speaker 3: have people that fly in, so they have to establish
- 52:26Speaker 3: care by coming to Texas, you know, or be in Texas,
- 52:30Speaker 3: and then we do a lot of virtual outside of that,
- 52:32Speaker 3: they just have to establish care and do physical visits
- 52:35Speaker 3: from time to time just to continue to be able
- 52:38Speaker 3: to be seen.
- 52:39Speaker 2: So, so, what are some of the biggest challenges that
- 52:43Speaker 2: are facing you right now?
- 52:45Speaker 3: You know, I would say, you know, it's always, you know,
- 52:47Speaker 3: it's always funding. Funding is very difficult for female founded companies.
- 52:51Speaker 3: We get less than one percent, you know, occasionally one
- 52:54Speaker 3: to three percent depending on what you're looking at, but
- 52:56Speaker 3: we get almost no investable dollars, despite the fact that
- 52:59Speaker 3: we usually outperform all founded companies, and so, you know,
- 53:03Speaker 3: that's the biggest challenge is having the right resources at
- 53:05Speaker 3: the right time to build things right. So that's been challenging.
- 53:09Speaker 3: Although we had a really successful friends and family round
- 53:12Speaker 3: and we're now you know, getting ready to go out
- 53:14Speaker 3: and get another round of precede investment. We are going
- 53:18Speaker 3: to self fund most of what's happening though, So we're
- 53:20Speaker 3: going to use our own revenue to grow so we
- 53:24Speaker 3: can grow organically and provide better value to our shareholders.
- 53:29Speaker 1: You know.
- 53:29Speaker 3: So i'd see that's the challenge, because of course I
- 53:31Speaker 3: want to see it out there. I'm one of those
- 53:32Speaker 3: people that I already see the end point. Like I'm like,
- 53:34Speaker 3: I know what it's going to look like ten years.
- 53:35Speaker 3: I want ten years today.
- 53:37Speaker 2: And well you know if you if you listen, sorry
- 53:41Speaker 2: but if you listen to Ben Hardy, I don't know if.
- 53:43Speaker 1: You know Ben Bendy.
- 53:44Speaker 2: Yeah, So he's been on my podcast and I adore him,
- 53:47Speaker 2: and you know, he always says, if you think about
- 53:50Speaker 2: what you want ten years from now, you can be today.
- 53:54Speaker 1: You just have to you just have to scale it.
- 53:57Speaker 1: So he calls it that what is it ten x
- 53:59Speaker 1: or something like that. But yeah, so you're you're writing
- 54:02Speaker 1: his camp.
- 54:03Speaker 2: You're there, You're the perfect poster child for what he's
- 54:06Speaker 2: what he's preaching.
- 54:08Speaker 3: Absolutely, Yeah, I love I love Ben.
- 54:10Speaker 1: Yes, so, and we also have Tracy. Tracy Wood is
- 54:14Speaker 1: our common connection, right.
- 54:17Speaker 3: Yes, I've done Tracy for quite a while. She's so fun.
- 54:19Speaker 1: So check out Top Doctor magazine.
- 54:22Speaker 2: She was just featured and one of I write a
- 54:25Speaker 2: column monthly there for top Doctor, and she we.
- 54:28Speaker 1: Just featured her. We featured gosh, you.
- 54:31Speaker 2: Know con a couple of years ago, and that's how
- 54:34Speaker 2: I got to meet Tracy. But so Tracy would for
- 54:37Speaker 2: everybody that doesn't know, is the CEO current CEO of
- 54:41Speaker 2: the DNA company, which is the genetics company that I
- 54:45Speaker 2: tell everybody you know that Kim Wrestler at SNIP Nutrition Neutronomics.
- 54:51Speaker 2: Those two companies are the ones that I recommend for
- 54:54Speaker 2: getting your baseline foundation of.
- 54:56Speaker 1: Your home, your health home, which is your genetics. So yeah,
- 55:00Speaker 1: those are two good ones. So where do you see
- 55:04Speaker 1: the future of healthcare? They they you know, you can't open.
- 55:08Speaker 2: The Internet without seeing the yeah, you know, the different biohackers,
- 55:12Speaker 2: and you know, this is the best time to ever
- 55:15Speaker 2: be alive. Don't die in the next ten years because
- 55:18Speaker 2: the next ten years, like the last ten years, will
- 55:20Speaker 2: be like the prior one hundred years.
- 55:23Speaker 1: So there's so.
- 55:23Speaker 2: Much happening technologically and so forth. What do you see
- 55:27Speaker 2: personally for the future of healthcare?
- 55:30Speaker 3: Yeah, so I think, I mean, I think it's several things.
- 55:33Speaker 3: You know, obviously, bioregulators, peptides. I'm getting involved with a
- 55:37Speaker 3: group that's going to be doing an i RB SO
- 55:39Speaker 3: an Institutional Review Board FDA research on peptides in our clinic.
- 55:46Speaker 3: You know, the reality is we have a lot of
- 55:50Speaker 3: opportunity through technology to advance human health span. That's what's
- 55:56Speaker 3: important to me. I don't want to live a long
- 55:57Speaker 3: time unless I'm healthy, you know, And so it's the
- 56:01Speaker 3: beauty is I think I think with all the different
- 56:03Speaker 3: technologies that we have, we're going to advance human health
- 56:07Speaker 3: for a lot longer health span. And and I think
- 56:10Speaker 3: it's a blending of the natural and the very cutting
- 56:13Speaker 3: edge science. You know, things like David Sinclair's work. You know,
- 56:17Speaker 3: we can't just look at it and go, I'm going
- 56:19Speaker 3: to go get hemlock and some you know, holy basil,
- 56:22Speaker 3: and that's going to maybe live one hundred and twenty.
- 56:24Speaker 3: We ma that other side of the technology. And so
- 56:27Speaker 3: I and I think this is a beautiful time. And
- 56:29Speaker 3: I think it's it's jumping in there and getting educated
- 56:33Speaker 3: and being open to new opportunities on both sides of
- 56:36Speaker 3: that fence.
- 56:37Speaker 2: And you know, one of the things that gets me
- 56:40Speaker 2: concerned is if with all this technology, if people's attitudes
- 56:44Speaker 2: towards coexistence, towards loving each other, towards being you know,
- 56:50Speaker 2: whether you have a different opinion or not, that you're
- 56:52Speaker 2: still willing to listen and tolerate and moves back.
- 56:56Speaker 1: And the connectedness is the you know, the fifth leg.
- 56:59Speaker 2: Of that tool that they talk about with you know,
- 57:02Speaker 2: when you when you talk about what are the influences
- 57:05Speaker 2: on your longevity? Well, you know, the connectedness is often
- 57:08Speaker 2: one that doesn't get mentioned as much as your diet
- 57:12Speaker 2: and your exercise and your sleep, but it's really important
- 57:16Speaker 2: when they look at the blue zones. You know the
- 57:18Speaker 2: fact that people are you know, one hundred years old,
- 57:21Speaker 2: still socializing and they still you know, go out and
- 57:25Speaker 2: walk together and stuff. These are This is something that
- 57:29Speaker 2: I think our world today, being so divisive, is going
- 57:32Speaker 2: to really hurt itself from an individual to a collective
- 57:36Speaker 2: standpoint because we're not getting along.
- 57:39Speaker 3: I mean right, yeah, And.
- 57:43Speaker 1: I mean I just wish there were more and more
- 57:46Speaker 1: emphasis on that.
- 57:48Speaker 3: Yeah. No, I agree, Yeah, I completely agree.
- 57:51Speaker 1: Are you familiar with doctor Bill Lawrence?
- 57:54Speaker 2: Okay, so he's doing he's doctor Cavinson's protege.
- 57:59Speaker 1: He went to Saint Petersburg when knocked on their door.
- 58:02Speaker 2: They took him in, they trained him, and they made
- 58:05Speaker 2: him the US representative for the peptide bioregulators.
- 58:10Speaker 1: He's the man to.
- 58:11Speaker 2: Know if you're going to start getting into and I'm
- 58:13Speaker 2: happy to introduce you if you like.
- 58:15Speaker 1: So I'm in his clinical trials. I've been in him
- 58:17Speaker 1: for three years because he was.
- 58:19Speaker 2: On my podcast through Phil Mickens, who you know, you
- 58:23Speaker 2: can get a lot of peptides out of Phil Mickens
- 58:26Speaker 2: company anti aging systems. But he introduced me to Bill
- 58:31Speaker 2: Lawrence because he's doing the science behind all of.
- 58:34Speaker 4: This, and so anyway, I really respect him and that
- 58:38Speaker 4: you know, a lot of people don't understand that you
- 58:40Speaker 4: can get peptides orally if you don't like in chet and.
- 58:44Speaker 2: The peptide bioregulators have been in Russia for over forty years.
- 58:48Speaker 2: They've been selling them in pharmacy over the counter, so
- 58:53Speaker 2: Russia they're considered just a regular pill, whereas here.
- 58:58Speaker 1: You know, there's still under a lot of scrutiny.
- 59:01Speaker 2: But all those peptides that you get to inject, you
- 59:04Speaker 2: can also take orally if you prefer that.
- 59:08Speaker 1: So anyway, but he does a lot of focus.
- 59:12Speaker 2: On ones like epicalon which helps you because he does.
- 59:16Speaker 2: For his baseline test is to test your telemeres. Yeah,
- 59:20Speaker 2: and then and along with that your biological age.
- 59:23Speaker 1: So let's talk about that for a moment, because that's
- 59:25Speaker 1: always an interesting topic.
- 59:27Speaker 2: Is your biological versus your chronological I think, honestly, Betty,
- 59:31Speaker 2: I think if people ask him your age, you should
- 59:33Speaker 2: tell them only biological age.
- 59:35Speaker 3: I agree, I agree, Yeah, that's the biological age. Is
- 59:38Speaker 3: the aging of your system, not the chronological Yeah, no,
- 59:41Speaker 3: I agree completely. You know, at the end of the day,
- 59:43Speaker 3: that's the one that matters, right.
- 59:45Speaker 1: Exactly, because your chronological age.
- 59:47Speaker 2: I mean, yeah, you've been around the sun a few times,
- 59:50Speaker 2: but if your biological age is ten or fifteen or
- 59:52Speaker 2: twenty years younger, that's far more descriptive of who you
- 59:56Speaker 2: are as a functioning human being then how many times
- 1:00:00Speaker 2: you've been around the sun.
- 1:00:02Speaker 1: So, so have.
- 1:00:04Speaker 2: You done have you tested your biological.
- 1:00:07Speaker 3: It's been a while. Yeah, it's been a while. My
- 1:00:09Speaker 3: biological age. Last I tested, it was like forty eight
- 1:00:11Speaker 3: and I'm fifty six.
- 1:00:12Speaker 1: Wow.
- 1:00:13Speaker 3: Yeah, So I was like, I think probably depends on
- 1:00:16Speaker 3: the year. Last year was a crazy year, so it
- 1:00:18Speaker 3: might not be as great this.
- 1:00:19Speaker 2: Year, but still you know, it's at least twenty years
- 1:00:23Speaker 2: younger than your chronological so Beddy, I was just signaled
- 1:00:27Speaker 2: by Tony that we have to end because you have
- 1:00:29Speaker 2: to go to another podcast, So I'm going to say
- 1:00:32Speaker 2: good bye to you, but I just want before we go.
- 1:00:34Speaker 2: I know you said you wanted to offer something to
- 1:00:37Speaker 2: our viewers, So why don't you tell us what that
- 1:00:39Speaker 2: is and how? I thank you very much for for
- 1:00:44Speaker 2: your generosity, So could you just give us a quickening
- 1:00:46Speaker 2: on that.
- 1:00:47Speaker 3: Sure, it's it's an e book. It's called the Fierce
- 1:00:49Speaker 3: Female Method for Long for Longevity and the U r
- 1:00:54Speaker 3: L is fierce, so the word fierce dot hormones help
- 1:00:58Speaker 3: dot com.
- 1:00:59Speaker 1: And you can feel so e r C for anyone
- 1:01:03Speaker 1: that doesn't know.
- 1:01:04Speaker 3: I always have to write it down and look at it.
- 1:01:07Speaker 3: But yeah, so it's it's got a lot of the
- 1:01:08Speaker 3: information that we kind of covered today in a little
- 1:01:11Speaker 3: bit about how to biohack aging and so thanks.
- 1:01:14Speaker 1: I need to use the ageless code to get that.
- 1:01:18Speaker 3: They can go straight there. Yeah, okay, so.
- 1:01:20Speaker 1: We'll get it regardless of okay, perfect.
- 1:01:23Speaker 3: Well.
- 1:01:23Speaker 2: I so enjoyed having you on, Betty. I've been waiting
- 1:01:26Speaker 2: for this for I guess it's been like nine months.
- 1:01:28Speaker 3: Yeah, it's been a long time.